Citrate in Pediatric CNS Tumors?

• Published in: American journal of neuroradiology : AJNR 2008-05, Vol.29 (5), p.1006-1011
• Main Authors: Seymour, Z.A, Panigrahy, A, Finlay, J.L, Nelson, M.D., Jr, Bluml, S
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Biological and medical sciences; Biomarkers - metabolism; Brain - metabolism; Brain Neoplasms - metabolism; Child; Child, Preschool; Citric Acid - metabolism; Female; Humans; Infant; Infant, Newborn; Investigative techniques, diagnostic techniques (general aspects); Magnetic Resonance Spectroscopy - methods; Male; Medical sciences; Nervous system; Pediatrics; Radiodiagnosis. Nmr imagery. Nmr spectrometry
• ISSN: 0195-6108; 1936-959X
• DOI: 10.3174/ajnr.A1018

In a subset of in vivo MR spectra acquired from pediatric brain tumors, we have observed an unassigned peak. The goal of this study was to determine the molecule of origin, and the prevalence and concentration of this chemical in various pediatric brain tumors. Single-voxel point-resolved spectroscopy (PRESS) spectra from 85 patients with brain tumors and 469 control subjects were analyzed. Citrate seemed to be a likely candidate, and model spectra of citrate were added to the basis set of metabolites for automated processing with use of LCModel software. Absolute "apparent" concentrations of citrate and the Cramer-Rao lower bounds (CRLB), indicators for the reliability of detection, were determined. "Apparent" citrate was detected in 26 of 85 patients with CRLB of less than 25%. Diffuse intrinsic brain stem glioma (DIBSG) had the highest mean concentration (4.0 +/- 1.1 mmol/kg in all subjects), and 8 of 12 patients had CRLB less than 25%. A significant reduction of citrate (P < .01) was observed in 6 DIBSGs that had follow-up MR spectroscopy studies after radiation therapy. "Apparent" citrate with CRLB less than 25% was detected in 5 of 22 medulloblastomas (mean citrate, 2.9 +/- 2.2 mmol/kg), in 5 of 14 ependymomas (2.6 +/- 1.8 mmol/kg), 5 of 14 astrocytomas (1.9 +/- 1.2 mmol/kg), and 3 of 23 pilocytic astrocytomas (1.4 +/- 1.1 mmol/kg). In control subjects older than 6 months, CRLB less than 25% was not observed, whereas CRLB less than 25% was observed in 39 of 194 subjects younger than 6 months,. MR signal consistent with citrate was observed in pediatric brain tumors and in the developing brain of infants younger than 6 months.